Tech Company Financing Transactions
SPR Therapeutics Funding Round
SPR Therapeutics secured a $85 million Series D funding round on 2/1/2024. Backers included Revelation Partners and Mutual Capital Partners.
Transaction Overview
Company Name
Announced On
2/1/2024
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$85,000,000
Round
Series D
Investors
Revelation Partners (Lead Investor)
Proceeds Purpose
The company intends to use the funds to capitalize on commercial momentum, customer demand, and market opportunity to expand its sales representation in additional U.S. sales territories. In addition to sales expansion, proceeds will support continued product development.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
22901 Millcreek Blvd. 110
Cleveland, OH 44122
USA
Cleveland, OH 44122
USA
Phone
Website
Email Address
Overview
SPR Therapeutics is a medical device company that is commercializing pain treatments utilizing its proprietary peripheral nerve stimulation (PNS) products. We are developing a pipeline of neurostimulation pain therapies that will exploit the same physiologic mechanism of action, proprietary technology, and clinical approach.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Maria Bennett
Chief Medical Officer
John Chae
Chief Scientific Officer
Warren Grill
VP - Marketing
Mark Stultz
VP - R & D
Joseph Boggs
VP - Sales
David Youngberg
Browse more venture capital transactions:
Prev: 2/1/2024: Izote Biosciences venture capital transaction
Next: 2/1/2024: Harbor venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs